Yetkin Agackiran

Yetkin Agackiran

Auto-generated profile, based on publicly available information

Yetkin Agackiran

Department of Pathology, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Kecioren, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
EAErtan Aydin
Ertan Aydin
UYUlku Yazici
Ulku Yazici
MGMahmut Gulgosteren
Mahmut Gulgosteren
YAYetkin Agackiran
Yetkin Agackiran
SKSadi Kaya
Sadi Kaya
NKNurettin Karaoglanoglu
Nurettin Karaoglanoglu
Pulmonary carcinoid tumors are rare low-grade malignant neoplasms and constitute 2-5% of all lung tumors. In this study, we aimed to determine the clinical presentations, types of surgery, long-term treatment outcomes and survival rates of patients diagnosed with carcinoid tumor treated surgically in our clinic. Patients operated in our clinic between 1992 and 2008 with confirmed or suspected diagnoses of carcinoid tumors were included in our study. Patients' hospital records were retrospectively analyzed. A total of 104 patients (age 19-71 years, mean 44±13 years, 2 SD) with pathologically confirmed carcinoid tumor were analyzed. A total of 84 patients (81%) were diagnosed as typical and the remaining 20 (19%) being atypical carcinoid tumor. As many as 24 patients (23%) were asymptomatic. The most frequent symptom was recurrent respiratory infection (35%). The most used surgical procedures were lobectomy (47%) and bilobectomy (16%). Mean postoperative follow-up period was 72 months (6-190 months). No surgery related mortality was noticed. As many as 15 (14%) patients died during the follow-up period. Overall 5- and 10-year survival rates were 89% and 72%, respectively. For typical carcinoid tumors, the 5- and 10-year survival rates were 92% and 83%, and for atypical carcinoids 73% and 46%, respectively (p<0.001). In our study, we noticed histological subtype, stage of the disease and the type of surgery performed to be prognostic factors of carcinoid tumors. Atypical carcinoid tumors tend to be more metastatic and had worse prognosis when compared with typical carcinoid tumors. We conclude that surgery is the best treatment of choice for carcinoid tumors, especially parenchyma-sparing procedures, because of their good mid- and long-term survival rates.

1 July 2012 in Applied Immunohistochemistry & Molecular Morphology
Verified
Journal Article
Closed access
YAYetkin Agackiran
Yetkin Agackiran
AOAysenaz Ozcan
Aysenaz Ozcan
NANalan Akyurek
Nalan Akyurek
LMLeyla Memis
Leyla Memis
GFGokturk Findik
Gokturk Findik
SKSadi Kaya
Sadi Kaya
The treatment strategy of differentiating lung carcinomas into small-cell lung carcinoma and non-small-cell lung carcinoma has been satisfactory until recently. The introduction of novel cytotoxic agents that affect a patient's response to therapy has made further differentiation important. Non-small-cell carcinoma represents a heterogeneous group of cancers with varying histologic subtypes, hence the necessity to subgroup them. In the case of adenocarcinoma and squamous cell cancer, their different responses to novel therapeutic agents and their higher occurrence make differentiation between them even more important. New markers such as desmoglein-3 (positive for squamous carcinoma) and Napsin A (positive for adenocarcinoma), which show improved specificity and sensitivity, may be particularly useful for this type of differentiation. In our study, 124 surgically resected specimens were used: 57 adenocarcinoma, 42 squamous cell carcinoma, 16 large-cell carcinoma, 1 small-cell carcinoma, and 8 typical carcinoid tumor samples. The sensitivity to desmoglein-3 and Napsin A was 92.8% and 85.9%, whereas specificity was 100% and 97%, respectively. The use of a desmoglein-3 and Napsin A double-staining strategy in our study confirmed that these markers are useful in differentiating pulmonary squamous cell carcinoma and pulmonary adenocarcinoma from other subtypes.

1 January 2014 in Turkish Journal of Pathology
Verified
Journal Article
Open access
YAYetkin Agackiran
Yetkin Agackiran
GFGokturk Findik
Gokturk Findik
LULeyla N. Ustun
Leyla N. Ustun
KAKoray Aydogdu
Koray Aydogdu
SKSadi Kaya
Sadi Kaya
Benign metastasizing leiomyoma is typically seen in young premenopausal women after a mean period of 15 years following uterine leiomyoma or hysterectomy surgery. They are usually incidentally seen on chest x-rays and are nodular lesions that appear as bilateral nodules with a benign appearance and consist of smooth muscle proliferation. A 44-year-old female presented at her healthcare institution for backache for the last 9 months. Multiple nodules (largest 15 mm) scattered in both lungs and consistent with metastases were detected on computed tomography. The PET-CT results revealed multiple nodular densities with increased metabolic activity (SUVmax: 1.92) in both lungs, with the largest one measuring approximately 15 mm and located in the lower lobe superior segment of the right lung. A benign metastasizing leiomyoma was diagnosed with open wedge biopsy of the lung. We present this case due to its interesting clinical presentation and rarity and emphasize the pathogenesis.

1 September 2004 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
SGS.S.ERkmen Gülhan
S.S.ERkmen Gülhan
PAPinar Yaran Adams
Pinar Yaran Adams
ESErkin A. Sarıca
Erkin A. Sarıca
HTHasan Türüt
Hasan Türüt
YAYetkin Agackıran
Yetkin Agackıran

1 April 2008 in Journal of Surgical Research
Verified
Journal Article
Closed access
MSMehmet Sırmalı
Mehmet Sırmalı
EUEfkan Uz
Efkan Uz
RSRana Sırmalı
Rana Sırmalı
AKAynur Kılbaş
Aynur Kılbaş
HYH. Ramazan Yılmaz
H. Ramazan Yılmaz
NDNamık Delibaş
Namık Delibaş

27 March 2009 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
AYAhmet Yesildağ
Ahmet Yesildağ
AÖAhmet Özden
Ahmet Özden
HYH. Ramazan Yılmaz
H. Ramazan Yılmaz
EUEfkan Uz
Efkan Uz
YAYetkin Ağackıran
Yetkin Ağackıran
MNMustafa Nazıroğlu
Mustafa Nazıroğlu